FR 2021-03535

Overview

Title

Agency Information Collection Activities: Submission for OMB Review; Comment Request

Agencies

ELI5 AI

The Centers for Medicare & Medicaid Services wants to know what people think about their plans to ask for information, like how they're handling things with medicines' prices, so they can make sure they're doing a good job and making it easier for everyone. They want people to tell them by March 25 if they think their ideas are good or if they have better ones.

Summary AI

The Centers for Medicare & Medicaid Services (CMS) is asking for public comments on plans to gather information from the public under the Paperwork Reduction Act. This involves several forms related to the Medicaid Drug Rebate Program, which they are updating to handle new data formats and higher drug prices. They require input on the accuracy of their burden estimates and suggestions to improve information collection. Comments must be submitted by March 25, 2021, as noted in the Federal Register.

Abstract

The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS' intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (PRA), federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, and to allow a second opportunity for public comment on the notice. Interested persons are invited to send comments regarding the burden estimate or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agency's functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden.

Type: Notice
Citation: 86 FR 10971
Document #: 2021-03535
Date:
Volume: 86
Pages: 10971-10972

AnalysisAI

The document in question is a public notice from the Centers for Medicare & Medicaid Services (CMS), appearing in the Federal Register, inviting comments on proposed updates to the Medicaid Drug Rebate Program forms. This invitation aligns with the requirements of the Paperwork Reduction Act, a law intended to minimize paperwork burden on the public. The updates aim to accommodate new data formats and address the increased prices of drugs.

General Summary

The primary purpose of the document is to solicit input from the public about CMS's plans to collect information related to the Medicaid Drug Rebate Program. The notice specifically highlights changes involving the introduction of new data file formats and increased field sizes for forms used by drug manufacturers and states. It details the necessity for feedback on several aspects, including the accuracy of their burden estimates, the utility of new information, and potential improvements.

Significant Issues and Concerns

While the document effectively outlines the procedural aspects of the information collection, several issues might interest or concern the public:

  1. Lack of Cost Transparency: The document does not provide an estimated cost associated with implementing the information collection processes, leaving an important component of financial accountability unaddressed.

  2. Potential for Favoritism: There's no clarity on mechanisms to prevent bias or favoritism towards certain entities within the collection process, a detail that could be critical for maintaining fair operations.

  3. Complex Language and Details: The technical language and IT-related specifics about the updates may be difficult for individuals without technical expertise to understand. A more simplified approach or additional guidance could enhance accessibility.

  4. Impact of Public Comments: Although the document mentions that public comments are welcome, it does not clearly specify how those will influence CMS's decision-making. Greater transparency in this area could encourage more meaningful public engagement.

  5. Regulatory References: The inclusion of legal references without context may make the document challenging for those unfamiliar with specific laws and regulations. Summarizing these references could make the document more user-friendly.

Impact on the Public and Stakeholders

For the broader public, these updates can signify an improvement in the efficiency and accuracy of Medicaid drug rebate processing, potentially translating into better healthcare service delivery. However, the impact largely depends on how effectively CMS can incorporate public feedback and implement changes without causing confusion or increased administrative burden.

Specific stakeholders, such as pharmaceutical companies (the private sector) and state governments, stand to be most directly affected. For drug manufacturers, the changes in form formats and requirements might necessitate adjustments in data tracking and reporting systems. While this could pose an initial challenge, the updated formats can eventually lead to streamlined processes.

For state governments, the adjustments may require realignment of reporting mechanisms and could impact how rebates are managed. Yet, if implemented with consideration to public and stakeholder input, these changes could lead to more effective financial management in state Medicaid programs.

In conclusion, while the CMS notice is a necessary step in regulatory compliance and program improvement, it presents opportunities for refinement in communication and engagement practices. Enhanced clarity and transparency could bolster public trust and facilitate smoother transitions in these regulatory updates.

Issues

  • • The document does not specify the total estimated cost of implementing the proposed information collections, which would provide insight into potential wasteful spending.

  • • The document does not outline any measures put in place to prevent favoritism towards certain organizations or individuals in the collection process.

  • • The language regarding the necessity and utility of the proposed information collection for the proper performance of the agency's functions is somewhat vague and could benefit from more specificity.

  • • The technical details about file format changes and updates might be difficult to understand for individuals not familiar with IT systems, suggesting a need for simplification or additional guidance.

  • • The document could benefit from a clearer explanation of how public comments will directly impact the decision-making process, making it more transparent for interested parties.

  • • The document references specific codes and legal references (such as 44 U.S.C. 3501-3520) without providing context or summaries for those unfamiliar with such regulations, making it inaccessible to a general audience.

  • • The count of individuals or entities affected by these collections, especially stating the affected public as 'Private sector (Business or other for-profits)' and 'State, Local, or Tribal Governments', could be further detailed to enhance clarity.

Statistics

Size

Pages: 2
Words: 1,652
Sentences: 54
Entities: 127

Language

Nouns: 594
Verbs: 116
Adjectives: 59
Adverbs: 24
Numbers: 79

Complexity

Average Token Length:
5.26
Average Sentence Length:
30.59
Token Entropy:
5.31
Readability (ARI):
22.12

Reading Time

about 6 minutes